{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:33:06Z","timestamp":1795008786047,"version":"4.9.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52908-z","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T11:03:04Z","timestamp":1728039784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate"],"prefix":"10.1038","volume":"15","author":[{"given":"Dan","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3173-4301","authenticated-orcid":false,"given":"Renqi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwu","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5796-8851","authenticated-orcid":false,"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9866-2384","authenticated-orcid":false,"given":"Zihe","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-2708","authenticated-orcid":false,"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8109-7515","authenticated-orcid":false,"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"52908_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1152\/physrev.1978.58.2.317","volume":"58","author":"HN Munro","year":"1978","unstructured":"Munro, H. N. & Linder, M. C. Ferritin: structure, biosynthesis, and role in iron metabolism. Physiol. Rev. 58, 317\u2013396 (1978).","journal-title":"Physiol. Rev."},{"key":"52908_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","volume":"1275","author":"PM Harrison","year":"1996","unstructured":"Harrison, P. M. & Arosio, P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta (BBA) Bioenerg. 1275, 161\u2013203 (1996).","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"52908_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/am.2016.128","volume":"9","author":"S Bhaskar","year":"2017","unstructured":"Bhaskar, S. & Lim, S. Engineering protein nanocages as carriers for biomedical applications. NPG Asia Mater. 9, e371 (2017).","journal-title":"NPG Asia Mater."},{"key":"52908_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7150\/ntno.19796","volume":"1","author":"S Chattopadhyay","year":"2017","unstructured":"Chattopadhyay, S., Chen, J. Y., Chen, H. W. & Hu, C. J. Nanoparticle vaccines adopting virus-like features for enhanced immune potentiation. Nanotheranostics 1, 244\u2013260 (2017).","journal-title":"Nanotheranostics"},{"key":"52908_CR5","doi-asserted-by":"crossref","unstructured":"Gomes, A. C., Mohsen, M. & Bachmann M. F. Harnessing nanoparticles for immunomodulation and vaccines. Vaccines 5, 6 (2017).","DOI":"10.3390\/vaccines5010006"},{"key":"52908_CR6","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","volume":"9","author":"R Pati","year":"2018","unstructured":"Pati, R., Shevtsov, M. & Sonawane, A. Nanoparticle vaccines against infectious diseases. Front. Immunol. 9, 2224 (2018).","journal-title":"Front. Immunol."},{"key":"52908_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3488","volume":"13","author":"DM Smith","year":"2013","unstructured":"Smith, D. M., Simon, J. K. & Baker, J. R. Jr. Applications of nanotechnology for immunology. Nat. Rev. Immunol. 13, 592\u2013605 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"52908_CR8","doi-asserted-by":"publisher","first-page":"5746","DOI":"10.1039\/C9NR08958F","volume":"12","author":"P Lung","year":"2020","unstructured":"Lung, P., Yang, J. & Li, Q. Nanoparticle formulated vaccines: opportunities and challenges. Nanoscale 12, 5746\u20135763 (2020).","journal-title":"Nanoscale"},{"key":"52908_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"M Kanekiyo","year":"2013","unstructured":"Kanekiyo, M. et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499, 102\u2013106 (2013).","journal-title":"Nature"},{"key":"52908_CR10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","volume":"162","author":"M Kanekiyo","year":"2015","unstructured":"Kanekiyo, M. et al. Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site. Cell 162, 1090\u20131100 (2015).","journal-title":"Cell"},{"key":"52908_CR11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","volume":"53","author":"X Ma","year":"2020","unstructured":"Ma, X. et al. Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses. Immunity 53, 1315\u20131330.e1319 (2020).","journal-title":"Immunity"},{"key":"52908_CR12","doi-asserted-by":"crossref","unstructured":"He, L. et al. Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates. Sci. Adv. 7, eabf1591 (2021).","DOI":"10.1126\/sciadv.abf1591"},{"key":"52908_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nano.2018.11.009","volume":"16","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Ferritin nanoparticle-based SpyTag\/SpyCatcher-enabled click vaccine for tumor immunotherapy. Nanomedicine 16, 69\u201378 (2019).","journal-title":"Nanomedicine"},{"key":"52908_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12041","volume":"7","author":"L He","year":"2016","unstructured":"He, L. et al. Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles. Nat. Commun. 7, 12041 (2016).","journal-title":"Nat. Commun."},{"key":"52908_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41591-021-01660-8","volume":"28","author":"KV Houser","year":"2022","unstructured":"Houser, K. V. et al. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial. Nat. Med. 28, 383\u2013391 (2022).","journal-title":"Nat. Med."},{"key":"52908_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-022-01041-8","volume":"7","author":"W Tai","year":"2022","unstructured":"Tai, W. et al. Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant. Signal Transduct. Target. Ther. 7, 173 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"52908_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-021-03594-0","volume":"594","author":"KO Saunders","year":"2021","unstructured":"Saunders, K. O. et al. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature 594, 553\u2013559 (2021).","journal-title":"Nature"},{"key":"52908_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1477-3155-9-22","volume":"9","author":"JC Caldeira","year":"2011","unstructured":"Caldeira, J. C. & Peabody, D. S. Thermal stability of RNA phage virus-like particles displaying foreign peptides. J. Nanobiotechnol. 9, 22 (2011).","journal-title":"J. Nanobiotechnol."},{"key":"52908_CR19","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00726-009-0365-1","volume":"38","author":"ME Janssens","year":"2010","unstructured":"Janssens, M. E. et al. Folding properties of the hepatitis B core as a carrier protein for vaccination research. Amino Acids 38, 1617\u20131626 (2010).","journal-title":"Amino Acids"},{"key":"52908_CR20","doi-asserted-by":"crossref","unstructured":"Rodrigues, M. Q., Alves, P. M. & Rold\u00e3o, A. Functionalizing ferritin nanoparticles for vaccine development. Pharmaceutics 13, 1621 (2021).","DOI":"10.3390\/pharmaceutics13101621"},{"key":"52908_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00330-7","volume":"6","author":"B Nguyen","year":"2021","unstructured":"Nguyen, B. & Tolia, N. H. Protein-based antigen presentation platforms for nanoparticle vaccines. NPJ Vaccines 6, 70 (2021).","journal-title":"NPJ Vaccines"},{"key":"52908_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj3107","volume":"7","author":"YN Zhang","year":"2021","unstructured":"Zhang, Y. N. et al. Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants. Sci. Adv. 7, eabj3107 (2021).","journal-title":"Sci. Adv."},{"key":"52908_CR23","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","volume":"15","author":"YF Kang","year":"2021","unstructured":"Kang, Y. F. et al. Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates. ACS Nano 15, 2738\u20132752 (2021).","journal-title":"ACS Nano"},{"key":"52908_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","volume":"121","author":"TR Daniels","year":"2006","unstructured":"Daniels, T. R., Delgado, T., Rodriguez, J. A., Helguera, G. & Penichet, M. L. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol. 121, 144\u2013158 (2006).","journal-title":"Clin. Immunol."},{"key":"52908_CR25","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1021\/acs.biochem.8b00006","volume":"57","author":"MD Kleven","year":"2018","unstructured":"Kleven, M. D., Jue, S. & Enns, C. A. Transferrin receptors TfR1 and TfR2 bind transferrin through differing mechanisms. Biochemistry 57, 1552\u20131559 (2018).","journal-title":"Biochemistry"},{"key":"52908_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","volume":"133","author":"H Kawabata","year":"2019","unstructured":"Kawabata, H. Transferrin and transferrin receptors update. Free Radic. Biol. Med. 133, 46\u201354 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"52908_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0092-8674(04)00130-8","volume":"116","author":"Y Cheng","year":"2004","unstructured":"Cheng, Y., Zak, O., Aisen, P., Harrison, S. C. & Walz, T. Structure of the human transferrin receptor-transferrin complex. Cell 116, 565\u2013576 (2004).","journal-title":"Cell"},{"key":"52908_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09098-w","volume":"10","author":"LC Montemiglio","year":"2019","unstructured":"Montemiglio, L. C. et al. Cryo-EM structure of the human ferritin-transferrin receptor 1 complex. Nat. Commun. 10, 1121 (2019).","journal-title":"Nat. Commun."},{"key":"52908_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1006\/jsbi.1999.4118","volume":"126","author":"ND Chasteen","year":"1999","unstructured":"Chasteen, N. D. & Harrison, P. M. Mineralization in ferritin: an efficient means of iron storage. J. Struct. Biol. 126, 182\u2013194 (1999).","journal-title":"J. Struct. Biol."},{"key":"52908_CR30","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1128\/MCB.01437-10","volume":"31","author":"T Asano","year":"2011","unstructured":"Asano, T. et al. Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells. Mol. Cell. Biol. 31, 2040\u20132052 (2011).","journal-title":"Mol. Cell. Biol."},{"key":"52908_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","volume":"509","author":"JD Mancias","year":"2014","unstructured":"Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W. & Kimmelman, A. C. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509, 105\u2013109 (2014).","journal-title":"Nature"},{"key":"52908_CR32","doi-asserted-by":"crossref","unstructured":"Mancias, J. D. et al. Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. Elife 4, e10308 (2015).","DOI":"10.7554\/eLife.10308"},{"key":"52908_CR33","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.bbagen.2017.07.015","volume":"1861","author":"M Gryzik","year":"2017","unstructured":"Gryzik, M. et al. Expression and characterization of the ferritin binding domain of nuclear receptor coactivator-4 (NCOA4). Biochim. Biophys. Acta Gen. Subj. 1861, 2710\u20132716 (2017).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"52908_CR34","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s00705-018-3814-x","volume":"163","author":"GK Amarasinghe","year":"2018","unstructured":"Amarasinghe, G. K. et al. Taxonomy of the order Mononegavirales: update 2018. Arch. Virol. 163, 2283\u20132294 (2018).","journal-title":"Arch. Virol."},{"key":"52908_CR35","doi-asserted-by":"crossref","unstructured":"Fooks, A. R. et al. Renewed public health threat from emerging lyssaviruses. Viruses 13, 1769 (2021).","DOI":"10.3390\/v13091769"},{"key":"52908_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/QCO.0000000000000420","volume":"31","author":"G Ugolini","year":"2018","unstructured":"Ugolini, G. & Hemachudha, T. Rabies: changing prophylaxis and new insights in pathophysiology. Curr. Opin. Infect. Dis. 31, 93\u2013101 (2018).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"52908_CR37","doi-asserted-by":"publisher","first-page":"560","DOI":"10.4103\/1319-2442.261327","volume":"30","author":"W Sriwijitalai","year":"2019","unstructured":"Sriwijitalai, W. & Wiwanitkit, V. Rabies, rabies vaccine, and renal failure: clinical issues. Saudi J. Kidney Dis. Transplant. 30, 560\u2013563 (2019).","journal-title":"Saudi J. Kidney Dis. Transplant."},{"key":"52908_CR38","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1474-4422(13)70038-3","volume":"12","author":"T Hemachudha","year":"2013","unstructured":"Hemachudha, T. et al. Human rabies: neuropathogenesis, diagnosis, and management. Lancet Neurol. 12, 498\u2013513 (2013).","journal-title":"Lancet Neurol."},{"key":"52908_CR39","doi-asserted-by":"crossref","unstructured":"Parize, P. et al. Systematic booster after rabies pre-exposure prophylaxis to alleviate rabies antibody monitoring in individuals at risk of occupational exposure. Vaccines 9, 309 (2021).","DOI":"10.3390\/vaccines9040309"},{"key":"52908_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S1286-4579(03)00075-3","volume":"5","author":"G Bordenave","year":"2003","unstructured":"Bordenave, G. Louis Pasteur (1822-1895). Microbes Infect. 5, 553\u2013560 (2003).","journal-title":"Microbes Infect."},{"key":"52908_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3181\/00379727-98-23997","volume":"98","author":"RE Kissling","year":"1958","unstructured":"Kissling, R. E. Growth of rabies virus in non-nervous tissue culture. Proc. Soc. Exp. Biol. Med. 98, 223\u2013225 (1958).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"52908_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0042-6822(65)90160-1","volume":"27","author":"A Kondo","year":"1965","unstructured":"Kondo, A. Growth characteristics of rabies virus in primary chick embryo cells. Virology 27, 199\u2013204 (1965).","journal-title":"Virology"},{"key":"52908_CR43","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","volume":"81","author":"TJ Wiktor","year":"1984","unstructured":"Wiktor, T. J. et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 81, 7194\u20137198 (1984).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"52908_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.virol.2015.10.029","volume":"489","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. A novel rabies vaccine based-on toll-like receptor 3 (TLR3) agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies. Virology 489, 165\u2013172 (2016).","journal-title":"Virology"},{"key":"52908_CR45","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.vaccine.2016.12.031","volume":"35","author":"L Wijaya","year":"2017","unstructured":"Wijaya, L. et al. An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers. Vaccine 35, 1175\u20131183 (2017).","journal-title":"Vaccine"},{"key":"52908_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.virs.2022.02.008","volume":"37","author":"M Liang","year":"2022","unstructured":"Liang, M. et al. A single dose of recombinant VSV-RABV(G) vaccine provides full protection against RABV challenge. Virol. Sin. 37, 455\u2013458 (2022).","journal-title":"Virol. Sin."},{"key":"52908_CR47","doi-asserted-by":"publisher","first-page":"11300","DOI":"10.1073\/pnas.0905640106","volume":"106","author":"M Faber","year":"2009","unstructured":"Faber, M. et al. Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc. Natl. Acad. Sci. USA 106, 11300\u201311305 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"52908_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1096\/fj.09-138644","volume":"24","author":"M Kaur","year":"2010","unstructured":"Kaur, M., Saxena, A., Rai, A. & Bhatnagar, R. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB\/c mice. FASEB J. 24, 173\u2013183 (2010).","journal-title":"FASEB J."},{"key":"52908_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.molimm.2017.02.011","volume":"85","author":"R Garg","year":"2017","unstructured":"Garg, R., Kaur, M., Saxena, A., Prasad, R. & Bhatnagar, R. Alum adjuvanted rabies DNA vaccine confers 80% protection against lethal 50 LD(50) rabies challenge virus standard strain. Mol. Immunol. 85, 166\u2013173 (2017).","journal-title":"Mol. Immunol."},{"key":"52908_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39421-5","volume":"14","author":"F Hellgren","year":"2023","unstructured":"Hellgren, F. et al. Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses. Nat. Commun. 14, 3713 (2023).","journal-title":"Nat. Commun."},{"key":"52908_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7774\/cevr.2015.4.1.107","volume":"4","author":"DK Yang","year":"2015","unstructured":"Yang, D. K. et al. Oral immunization of mice with recombinant rabies vaccine strain (ERAG3G) induces complete protection. Clin. Exp. Vaccine Res. 4, 107\u2013113 (2015).","journal-title":"Clin. Exp. Vaccine Res."},{"key":"52908_CR52","unstructured":"World Health Organization. Food, Agriculture Organization of the United Nations, World Organisation for Animal Health. Zero By 30: The Global Strategic Plan to End Human Deaths from Dog-mediated Rabies by 2030 (World Health Organization, 2018)."},{"key":"52908_CR53","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1135710","volume":"315","author":"S Roche","year":"2007","unstructured":"Roche, S., Rey, F. A., Gaudin, Y. & Bressanelli, S. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science 315, 843\u2013848 (2007).","journal-title":"Science"},{"key":"52908_CR54","doi-asserted-by":"publisher","first-page":"e1004756","DOI":"10.1371\/journal.ppat.1004756","volume":"11","author":"E Baquero","year":"2015","unstructured":"Baquero, E. et al. Structure of the low pH conformation of Chandipura virus G reveals important features in the evolution of the vesiculovirus glycoprotein. PLoS Pathog. 11, e1004756 (2015).","journal-title":"PLoS Pathog."},{"key":"52908_CR55","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nsmb.1484","volume":"15","author":"J Kadlec","year":"2008","unstructured":"Kadlec, J., Loureiro, S., Abrescia, N. G. A., Stuart, D. I. & Jones, I. M. The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat. Struct. Mol. Biol. 15, 1024\u20131030 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"52908_CR56","doi-asserted-by":"crossref","unstructured":"Vollmer, B. et al. The prefusion structure of herpes simplex virus glycoprotein B. Sci. Adv. 6, eabc1726 (2020).","DOI":"10.1126\/sciadv.abc1726"},{"key":"52908_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2022.101204","volume":"53","author":"GD de Melo","year":"2022","unstructured":"de Melo, G. D., Hellert, J., Gupta, R., Corti, D. & Bourhy, H. Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy. Curr. Opin. Virol. 53, 101204 (2022).","journal-title":"Curr. Opin. Virol."},{"key":"52908_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14398-7","volume":"11","author":"J Hellert","year":"2020","unstructured":"Hellert, J. et al. Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein. Nat. Commun. 11, 596 (2020).","journal-title":"Nat. Commun."},{"key":"52908_CR59","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.chom.2019.12.012","volume":"27","author":"F Yang","year":"2020","unstructured":"Yang, F. et al. Structural analysis of rabies virus glycoprotein reveals pH-dependent conformational changes and interactions with a neutralizing antibody. Cell Host Microbe 27, 441\u2013453.e447 (2020).","journal-title":"Cell Host Microbe"},{"key":"52908_CR60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/v4010117","volume":"4","author":"AA Albertini","year":"2012","unstructured":"Albertini, A. A., Baquero, E., Ferlin, A. & Gaudin, Y. Molecular and cellular aspects of rhabdovirus entry. Viruses 4, 117\u2013139 (2012).","journal-title":"Viruses"},{"key":"52908_CR61","unstructured":"World Health Organization. WHO Expert Consultation on Rabies: Second Report (World Health Organization, 2013)."},{"key":"52908_CR62","doi-asserted-by":"publisher","first-page":"284ra259","DOI":"10.1126\/scitranslmed.aaa4304","volume":"7","author":"HM Lazear","year":"2015","unstructured":"Lazear, H. M. et al. Interferon-\u03bb restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci. Transl. Med. 7, 284ra259 (2015).","journal-title":"Sci. Transl. Med."},{"key":"52908_CR63","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/jir.2010.0078","volume":"30","author":"RP Donnelly","year":"2010","unstructured":"Donnelly, R. P. & Kotenko, S. V. Interferon-lambda: a new addition to an old family. J. Interferon Cytokine Res. 30, 555\u2013564 (2010).","journal-title":"J. Interferon Cytokine Res."},{"key":"52908_CR64","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","volume":"278","author":"ES Rosenberg","year":"1997","unstructured":"Rosenberg, E. S. et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447\u20131450 (1997).","journal-title":"Science"},{"key":"52908_CR65","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu, J., Yamane, H. & Paul, W. E. Differentiation of effector CD4 T cell populations*. Annu. Rev. Immunol. 28, 445\u2013489 (2010).","journal-title":"Annu. Rev. Immunol."},{"key":"52908_CR66","doi-asserted-by":"crossref","unstructured":"Ertl, H. C. J. New rabies vaccines for use in humans. Vaccines 7, 54 (2019).","DOI":"10.3390\/vaccines7020054"},{"key":"52908_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48151-1","volume":"15","author":"F Hoelzgen","year":"2024","unstructured":"Hoelzgen, F. et al. Structural basis for the intracellular regulation of ferritin degradation. Nat. Commun. 15, 3802 (2024).","journal-title":"Nat. Commun."},{"key":"52908_CR68","doi-asserted-by":"publisher","first-page":"E690","DOI":"10.1073\/pnas.1115485109","volume":"109","author":"B Zakeri","year":"2012","unstructured":"Zakeri, B. et al. Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc. Natl. Acad. Sci. USA 109, E690\u2013E697 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"52908_CR69","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1126\/science.abb8923","volume":"368","author":"BS Graham","year":"2020","unstructured":"Graham, B. S. Rapid COVID-19 vaccine development. Science 368, 945\u2013946 (2020).","journal-title":"Science"},{"key":"52908_CR70","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).","journal-title":"eLife"},{"key":"52908_CR71","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"52908_CR72","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"52908_CR73","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"52908_CR74","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"52908_CR75","doi-asserted-by":"crossref","unstructured":"Otwinowski, Z. & Minor, W. [20] Processing of X-ray diffraction data collected in oscillation mode. in Methods in Enzymology (Academic Press, 1997).","DOI":"10.1016\/S0076-6879(97)76066-X"},{"key":"52908_CR76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"52908_CR77","unstructured":"World Organisation for Animal Health (WOAH). WOAH terrestrial manual 2023. In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (ed Health) (World Organisation for Animal Health, 2023)."},{"key":"52908_CR78","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12985-022-01919-7","volume":"19","author":"J Li","year":"2022","unstructured":"Li, J. et al. An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs. Virol. J. 19, 184 (2022).","journal-title":"Virol. J."},{"key":"52908_CR79","doi-asserted-by":"crossref","unstructured":"Tu, Z. et al. Inhibition of rabies virus by 1,2,3,4,6-penta-O-galloyl-\u03b2-d-Glucose involves mTOR-dependent autophagy. Viruses 10, 201 (2018).","DOI":"10.3390\/v10040201"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52908-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52908-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52908-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T12:04:44Z","timestamp":1728043484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52908-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52908"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52908-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.G., D.F., and P.Y. declare the following competing interests: patent has been filed for the Fagy-tag and self-assembly nanoparticle system presented here. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The rabies virus challenge experiment has obtained approval by the Animal Ethics Committee of Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences (IACUC of AMMS-11-2024-044). The mice immunization experiment has obtained approval by the Animal Ethics Committee of the College of Life Sciences, Nankai University (2024-SYDWLL-000177).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statements"}}],"article-number":"8601"}}